Peripheral blood lymphocyte/monocyte ratio as a useful prognostic factor in dogs with diffuse large B-cell lymphoma receiving chemoimmunotherapy
Articolo
Data di Pubblicazione:
2015
Citazione:
Peripheral blood lymphocyte/monocyte ratio as a useful prognostic factor in dogs with diffuse large B-cell lymphoma receiving chemoimmunotherapy / L. Marconato, V. Martini, D. Stefanello, P. Moretti, R. Ferrari, S. Comazzi, P. Laganga, F. Riondato, L. Aresu. - In: THE VETERINARY JOURNAL. - ISSN 1090-0233. - 206:2(2015 Nov), pp. 226-230. [10.1016/j.tvjl.2015.07.009]
Abstract:
Diffuse large B-cell lymphoma (DLBCL) is the most frequent canine lymphoid neoplasm. Despite treatment, the majority of dogs with DLBCL experience tumour relapse and consequently die, so practical models to characterise dogs with a poor prognosis are needed. This study examined whether the lymphocyte/monocyte ratio (LMR) can predict outcome in dogs with newly diagnosed DLBCL with regard to time-to-progression (TTP) and lymphoma specific survival (LSS).A retrospective study analysed the prognostic significance of LMR obtained at diagnosis by flow cytometry (based on morphological properties and CD45 expression) in 51 dogs that underwent complete staging and received the same treatment, comprising multi-agent chemotherapy and administration of an autologous vaccine. Dogs with an LMR ≤ 1.2 (30% of all cases) were found to have significantly shorter TTP and LSS, and it was concluded that LMR was a useful independent prognostic indicator with biological relevance in dogs with DLBCL treated with chemoimmunotherapy.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Chemoimmunotherapy; Diffuse large B-cell lymphoma; Dog; Lymphocyte-monocyte ratio; Prognosis; Animal Science and Zoology; Veterinary (all)
Elenco autori:
L. Marconato, V. Martini, D. Stefanello, P. Moretti, R. Ferrari, S. Comazzi, P. Laganga, F. Riondato, L. Aresu
Link alla scheda completa: